Key points from article :
Embotrap II is developed and marketed by Neuravi.
Small, mesh-like construct can restore blood flow through vessels by removing clots.
Designed to trap clot with minimal compression and rapidly deliver TICI 2b-3 reperfusion.
Now acquired by Codman Neuro, part of the Johnson & Johnson.